证券之星消息，1月13日医疗器械板块较上一交易日上涨0.39%，宝莱特领涨。当日上证指数报收于 4138.76，下跌0.64%。深证成指报收于14169.4，下跌1.37%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300246 | 宝莱特 | 13.09 | 19.98% | 47.22万 | | 6.06亿 | | 688277 | 天智航 | 22.03 | 16.62% | 52.26万 | | 10.94亿 | | 301097 | 天益医疗 | 58.50 | 14.12% | 3.55万 | | 2.03亿 | | 300406 | 九强生物 | 15.23 | 9.41% | 40.84万 | | 6.12亿 | | 301093 | 华兰股份 | 62.63 | 8.58% | 15.37万 | | 9.51亿 | | 688236 | 春立医疗 | 26.35 | 6.59% | 4.66万 | | 1.19亿 | | 30 ...

| | 板块名称 涨跌幅 (%) 板块资金流向 | | 净流入最大 | | --- | --- | --- | --- | | 电网设备 | 1.14 | 19.56亿元 | 特变电工 | | 医疗器械 | 1.28 | 13.32亿元 | 迈瑞医疗 | | 化学制药 | 1.23 | 11.16亿元 | 尔康制药 | | 能源金属 | 1.5 | 9.84亿元 | 赣锋锂业 | | 生物制品 | 2.53 | 9.09亿元 | 康乐卫士 | | 游戏 | 1.22 | 8.86亿元 | 掌趣科技 | | 医疗服务 | 3.45 | 8.42亿元 | 国际医学 | | --- | --- | --- | --- | | | 1.94 | 5.28亿元 | 海王生物 | | 银行 | 0.67 | 4.84亿元 | 农业银行 | | | 3.54 | 4.75亿元 | 湖南白银 | | 医药商业 贵金属 | | | | *数据仅供参考，不构成投资建议 据交易所数据显示，截至1月13日收盘，大盘主力资金净流出1805.56亿元。主力资金流入前十大板块分别为： 电网设备（19.56亿元）、 医疗器械（13.32亿 ...

Core Viewpoint - The data indicates significant capital inflows into various stocks, highlighting investor interest in specific sectors such as power equipment, communication devices, and gaming [1][2][3] Group 1: Stock Performance and Capital Inflows - TBEA (特变电工) saw a capital inflow of 1.846 billion, with a price increase of 10.01% [2] - Haige Communication (海格通信) experienced a capital inflow of 1.661 billion, with a price increase of 10% [2] - ZQ Game (掌趣科技) had a capital inflow of 0.791 billion, with a notable price increase of 14.91% [2] - Yonyou Network (用友网络) attracted 0.768 billion in capital, with a price increase of 7.87% [2] - Shanghai Construction (上海建工) received 0.603 billion, with a price increase of 10.14% [2] Group 2: Sector Analysis - The power equipment sector, represented by TBEA, shows strong investor confidence with significant capital inflows [2] - The communication device sector, including Haige Communication and Lian Te Technology (联特科技), also reflects positive investor sentiment [2][3] - The gaming industry, represented by ZQ Game and Century Huaman (世纪华通), demonstrates robust growth potential with substantial capital inflows [2][3] - The education sector, represented by Zhonggong Education (中公教育), shows a healthy capital inflow of 0.508 billion, indicating investor interest [2] - The energy metal sector, represented by Ganfeng Lithium (赣锋锂业) and Tianqi Lithium (天齐锂业), continues to attract investment, reflecting ongoing demand in the market [2][3]

Group 1 - The A-share market experienced overall fluctuations on January 13, with the medical device ETF (562600) rising by 1.47%. AI medical applications continued to show strength, with stocks like Di'an Diagnostics hitting the daily limit, Tianzhihang-U increasing by 17.79%, and Hualan Biological rising by 10.64% [1] - The medical device ETF (562600) has seen significant capital inflow, with a net inflow of 140 million over the past five days and 162 million over the past ten days. As of 14:00, the trading volume of the ETF reached 56.14 million, indicating a notable increase in trading activity [1] - At the JPMorgan Healthcare Conference on January 12, Nvidia and Eli Lilly announced a joint investment of 1 billion over five years to establish a new research lab in the San Francisco Bay Area aimed at accelerating AI drug development [1] Group 2 - Analysts predict that the AI medical industry is entering a golden development period, with innovations in AI-assisted medical imaging, smart surgical robots, and AI platforms for drug development accelerating. The industry is expected to expand further as AI technology continues to develop and healthcare demands increase [2] - The medical device industry is thriving, and the medical device ETF (562600) provides a convenient way to capture growth opportunities. The ETF tracks the CSI All-Share Medical Device Index, with a 23.8% allocation to brain-computer interfaces, the highest among similar ETFs, and a significant focus on leading companies like Mindray and Di'an Diagnostics [2] - For external investors, options such as the Huaxia CSI All-Share Medical Device ETF Initiated Link A (021250) and Link C (021251) are available for convenient investment [2]

Group 1 - The A-share market experienced significant fluctuations on January 13, with the medical device ETF (562600) showing strong performance, rising by 1.58% [1] - The medical technology sector is gaining momentum, driven by AI applications in healthcare, with companies like Di'an Diagnostics hitting the daily limit and Jiukang Bio rising by 12.86% [1] - The medical device ETF (562600) has seen a net inflow of 140 million yuan over the past five trading days, indicating investor confidence in the medical technology sector [1] Group 2 - The medical device ETF (562600) is a key tool for investing in cutting-edge medical technology, tracking the CSI All-Share Medical Device Index, with a significant 23.8% weight in brain-computer interface stocks [2] - The ETF has a high industry exposure of 89.2%, including leading companies like Mindray Medical, United Imaging, and Di'an Diagnostics, effectively capturing the benefits of niche market growth [2] - Investors can participate in the medical device ETF through low-threshold options like the Huaxia CSI All-Share Medical Device ETF Initiated Link A (021250) and C shares (021251) for long-term growth opportunities [2]

Group 1 - The medical device index ETF (159898) has shown strong performance, with a more than 2% increase in intraday trading, marking four consecutive days of gains, and a total net inflow of 342 million yuan over the past five trading days [1] - Strong Brain Technology, a Chinese brain-computer interface unicorn, has secretly submitted an IPO application in Hong Kong, potentially becoming the first listed company among the "Hangzhou Six Little Dragons," with a fundraising scale expected to reach several hundred million dollars [3] - The brain-computer interface sector is recognized as a significant technological breakthrough, with the national "14th Five-Year Plan" explicitly listing it as a future industry requiring forward-looking layout [3] Group 2 - The commercial pathway for brain-computer interfaces is expanding, with potential applications moving from medical rehabilitation to broader fields such as consumer electronics, smart homes, and industrial safety [3] - The global market for brain-computer interfaces is projected to exceed 10 billion dollars by 2030, with medical applications expected to dominate, and could grow to 145 billion dollars by 2040 [3] - The medical device index ETF (159898) tracks the CSI All-Share Medical Device Index, with 24% of its constituent stocks related to brain-computer interfaces, providing efficient coverage of this cutting-edge sector [4]

Core Viewpoint - By December 2025, over 500 national key laboratories have completed restructuring into a new sequence, with nearly 110 "Double First-Class" universities participating in about 80% (nearly 400) of the national key laboratories [1][2]. Group 1: National Key Laboratories Overview - National key laboratories are scientific research and development institutions planned by the state to support the national laboratory system, focusing on major technological innovation areas related to national security and socio-economic development [2]. - The restructuring of the national key laboratory system was first proposed at the Central Economic Work Conference in 2018 and established as a component of national strategic scientific and technological forces in the revised "Science and Technology Progress Law" in 2021 [2]. Group 2: Participation of Universities - The leading or co-building universities for the laboratories are primarily "Double First-Class" universities, indicating a strong involvement of top-tier educational institutions in the research initiatives [1][2]. - Nearly 110 "Double First-Class" universities are involved in the establishment and support of approximately 400 national key laboratories [1][2]. Group 3: List of Key Laboratories - A variety of national key laboratories have been established across different fields, including: - Dark Matter Physics National Key Laboratory led by Shanghai Jiao Tong University [3] - Explosive Science and Safety Protection National Key Laboratory led by Beijing Institute of Technology [3] - Materials Chemistry Engineering National Key Laboratory led by Nanjing University of Technology [3] - The list includes laboratories focusing on diverse areas such as intelligent transportation, infectious disease research, and advanced manufacturing technologies [3][4][5].

Group 1 - Nvidia and Eli Lilly will invest $1 billion over the next five years to establish an AI drug laboratory, focusing on accelerating medical discovery and production through robotics and physical AI [1] - The announcement has led to a significant rise in related pharmaceutical stocks, with Dean Diagnostics hitting the daily limit up for three consecutive trading days, and other companies like BGI Genomics and Berry Genomics seeing increases of over 16% and 8% respectively [1] - The medical device index ETF (159898) has gained 2.52% and has seen a net subscription of 366 million yuan over six consecutive days, indicating high market interest [1] Group 2 - Huafu Securities predicts that 2026 will mark the beginning of a new five-year period for AI healthcare, with expectations of more proactive fiscal signals supporting AI medical applications [2] - The current demand for AI applications in healthcare is expected to sustain the industry's long-term development, with recent events indicating a shift towards commercialization [2] - The National Medical Products Administration is expected to release ten measures by 2025-2026 to support the innovation and development of AI healthcare and high-end medical devices [2] Group 3 - The medical device index ETF (159898) tracks the CSI All-Share Medical Device Index, focusing entirely on the A-share medical device sector, with a pure beta quality [3] - The top ten holdings of the index include leading companies like Mindray Medical and United Imaging Healthcare, with over 80% of the portfolio in the ChiNext and STAR Market [3] Group 4 - The ETF's index includes a significant focus on brain-computer interface concepts, which account for approximately 24% of the index [4] - There is a scarcity of pure brain-computer interface stocks in the A-share market, presenting opportunities for capturing innovation in the industry [4] Group 5 - The medical device sector, which includes brain-computer interfaces, is expected to see substantial demand before and during the initial production phase of these technologies [5]

Core Insights - The article highlights significant growth in northbound capital flows into A-shares, with a record high in trading volume and a shift in investment preferences towards hard technology and non-ferrous metals sectors [1][2][3][4][5][6]. Group 1: Northbound Capital Trends - Northbound capital's total trading volume exceeded 50 trillion yuan for the first time in 2025, reaching 50.33 trillion yuan, marking a year-on-year increase of over 40% [3]. - By the end of 2025, the total market value of northbound capital holdings surpassed 2.5 trillion yuan, specifically reaching 2.59 trillion yuan, which is a nearly 20% increase from the previous year [2]. - The number of A-shares held by northbound capital remained above 1 trillion shares for four consecutive years, totaling nearly 1.08 trillion shares by the end of 2025 [2]. Group 2: ETF Trading Activity - Northbound capital's ETF trading volume exceeded 810 billion yuan in 2025, a 76% increase from 2024, with ETF transactions accounting for 1.62% of total northbound trading volume, both figures representing historical highs [4]. - The launch of the "ETF Connect" in July 2022 has significantly enhanced cross-border capital flows, providing a low-cost and efficient tool for foreign investors to access A-shares [4]. Group 3: Sector Preferences - There has been a notable shift in sector preferences, with hard technology and non-ferrous metals becoming favored sectors for northbound capital, contrasting with previous preferences for large financial and consumer sectors [6][7]. - By the end of 2025, the electric equipment sector led with a holding value exceeding 449.6 billion yuan, followed by the electronics sector at over 387 billion yuan, and non-ferrous metals at over 185.5 billion yuan [6]. Group 4: Market Dynamics - The concentration of northbound capital holdings has decreased to the lowest level in five years, indicating a trend towards a more diversified portfolio [9]. - The top 20 companies held by northbound capital accounted for less than 36% of total holdings, a decline of over 2 percentage points from 2021 [9]. Group 5: Performance of Specific Stocks - Eighteen stocks have seen continuous accumulation by northbound capital for five consecutive quarters, primarily in the machinery, electric equipment, and automotive sectors [10]. - Conversely, 26 stocks have experienced continuous reduction in holdings, mainly in the pharmaceutical, banking, and consumer sectors, with significant declines in their market performance [10].

Core Insights - Northbound capital has shown significant growth in trading activity and investment preferences, particularly favoring hard technology and non-ferrous metals sectors in 2025 [1][2][3][7]. Group 1: Market Performance - By the end of 2025, northbound capital held nearly 1.08 trillion shares of A-shares, with a market value surpassing 2.59 trillion yuan, marking a nearly 20% increase from the previous year [2]. - The total trading volume of northbound capital exceeded 50.33 trillion yuan in 2025, representing a more than 40% increase year-on-year, contributing nearly 6% to the overall A-share market trading volume [3]. - The trading activity of northbound capital reached new heights, with 33 trading days exceeding 300 billion yuan, 27 of which occurred in 2025 [3]. Group 2: ETF Trading - Northbound capital's ETF trading volume surpassed 810 billion yuan in 2025, a 76% increase from 2024, indicating a growing preference for ETF investments among foreign investors [4]. - The proportion of ETF trading in the total northbound capital trading volume reached 1.62%, setting a historical high [4]. Group 3: Sector Preferences - The hard technology and non-ferrous metals sectors emerged as the new favorites for northbound capital, with 14 industries seeing holdings exceed 50 billion yuan, and 10 industries surpassing 100 billion yuan [7]. - The electric equipment sector led with a holding value of over 449.6 billion yuan, followed by the electronics sector at over 387 billion yuan, and the non-ferrous metals sector at over 185.5 billion yuan [7]. - The non-ferrous metals sector saw a remarkable growth of over 172% in holdings compared to the end of 2024, reflecting a shift in investment focus [8]. Group 4: Stock Concentration - The concentration of holdings by northbound capital reached a five-year low in 2025, indicating a trend towards diversification in investment strategies [10]. - The top 20 companies held by northbound capital accounted for less than 36% of total holdings, a decrease of over 2 percentage points from 2021 [11]. Group 5: Popular Investment Themes - In 2025, eight out of ten popular investment themes, including commercial aerospace and semiconductor sectors, saw over 50% of their constituent stocks receiving increased holdings from northbound capital [9]. - The commercial aerospace sector, in particular, had over 80% of its stocks increased in holdings, driven by strong market performance and supportive policies [9]. Group 6: Long-term Trends - Eighteen stocks have been consistently increased in holdings for five consecutive quarters, primarily in the machinery, electric equipment, and automotive sectors, indicating strong institutional confidence [12]. - Conversely, 26 stocks have seen reductions in holdings over the same period, mainly in the pharmaceutical, banking, and consumer sectors, reflecting a shift in investment focus [12][13].